On July 31, 2025, WuXi AppTec Co., Ltd. (WuXi AppTec) announced that it has entered into a placing agreement with Morgan Stanley Asia Limited, Citigroup Global Markets Limited, Goldman Sachs (Asia) L.L.C., and The Hongkong and Shanghai Banking Corporation Limited (the Placing Agents), pursuant to which WuXi AppTec has agreed to appoint the Placing Agents and the Placing Agents have severally (but not jointly, nor jointly and severally) agreed to act as the agents of WuXi AppTec and to use their best efforts to procure certain investors to subscribe for a total of 73,800,000 new H Shares at HK$104.27 per placing share to be issued by WuXi AppTec under the general mandate upon the terms and subject to the conditions set out in the placing agreement (the Placing). The Placing is expected to raise $980 million to support WuXi AppTec’s global expansion.

WuXi AppTec is a trusted partner and contributor to the global pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation.

The Wilson Sonsini team that advised WuXi AppTec in the Placing includes Weiheng Chen, Yang Chu, Billy Yiu, and Kelly Cheng.